Search Results - "Rea, Rustam"

Experiences of Using a Digital Text Messaging Intervention to Support Oral Medication Adherence for People Living With Type 2 Diabetes: Qualitative Process Evaluation.

Authors: Newhouse, Nikki Bartlett, Yvonne Kiera Simao, Sara Correia et al.

Source: Journal of Medical Internet Research; 2025, Vol. 27, p1-18, 18p

Population-based management of diabetes care - approach and solutions used in the North East Locality Oxfordshire, UK Pilot.

Authors: Kozlowska, Olga Rea, Rustam Tan, Garry D. et al.

Source: International Journal of Integrated Care (IJIC). 2018 Supplement2, Vol. 18, p1-2. 2p.

Vascular risk: diabetes.

Authors: Collinson, Deborah J Rea, Rustam Donnelly, Richard

Source: Vascular Medicine. 2004, Vol. 9 Issue 4, p307-310. 4p.

REVIEW ARTICLE Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?

Authors: Rea, Rustam Donnelly, Richard

Source: Diabetes, Obesity & Metabolism. May2004, Vol. 6 Issue 3, p163-170. 8p.

Contrasting effects of insulin and cellular differentiation on expression of the novel insulin receptor substrate APS in skeletal muscle

Authors: Rea, Rustam Gray, Samuel Donnelly, Richard

Source: Biochemical Pharmacology. Nov2005, Vol. 70 Issue 9, p1309-1311. 3p.

A multi‐centre qualitative study of experiences of managing diabetes mellitus among adults while hospitalised.

Authors: Mansbridge, Sarah E. Kozlowska, Olga Lumb, Alistair et al.

Source: Diabetic Medicine. Apr2026, Vol. 43 Issue 4, p1-13. 13p.

Use of Brief Messages Based on Behavior Change Techniques to Encourage Medication Adherence in People With Type 2 Diabetes: Developmental Studies.

Authors: Bartlett, Yvonne Kiera Farmer, Andrew Rea, Rustam et al.

Source: Journal of Medical Internet Research; May2020, Vol. 22 Issue 5, pN.PAG-N.PAG, 1p, 7 Charts

Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial.

Authors: Farmer, Andrew J. Allen, Julie Bartlett, Y. Kiera et al.

Source: Pilot & Feasibility Studies. 1/25/2024, Vol. 10 Issue 1, p1-11. 11p.

Implementing a text message-based intervention to support type 2 diabetes medication adherence in primary care: a qualitative study with general practice staff.

Authors: Butler, Karen Bartlett, Yvonne Kiera Newhouse, Nikki et al.

Source: BMC Health Services Research. 6/10/2023, Vol. 23 Issue 1, p1-10. 10p.

...and Derby.

Authors: Rea, Rustam Farrell, Kyran Gregory, Simon et al.

Source: BMJ: British Medical Journal (Overseas & Retired Doctors Edition). 9/29/2012, Vol. 345 Issue 7876, p27-28. 2p.

Glucocorticoid‐induced hyperglycaemia in hospitalised adults: A matched cohort study (2013–2023).

Authors: Golubic, Rajna Mumbole, Hudson Coleman, Ruth L. et al.

Source: Diabetes, Obesity & Metabolism. Jul2025, Vol. 27 Issue 7, p3635-3644. 10p.

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19).

Authors: Llauradó, Gemma Vlacho, Bogdan Wargny, Matthieu et al.

Source: Cardiovascular Diabetology. 10/19/2022, Vol. 21 Issue 1, p1-18. 18p.

Distress and Living with Diabetes: Defining Characteristics Through an Online Survey.

Authors: Waheed, Unaiza Heald, Adrian H. Stedman, Mike et al.

Source: Diabetes Therapy. Sep2022, Vol. 13 Issue 9, p1585-1597. 13p.

Developing and exploring the validity of a patient reported experience measure for adult inpatient diabetes care.

Authors: Kozlowska, Olga Tallett, Amy Bond, Samuel et al.

Source: Diabetic Medicine. Apr2024, Vol. 41 Issue 4, p1-16. 16p.

A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID‐19.

Authors: Field, Benjamin C. T. Ruan, Yue Várnai, Kinga A. et al.

Source: Diabetes, Obesity & Metabolism. Jul2023, Vol. 25 Issue 7, p2012-2022. 11p.

Associations of microvascular complications with all‐cause death in patients with diabetes and COVID‐19: The CORONADO, ABCD COVID‐19 UK national audit and AMERICADO study groups.

Authors: Hadjadj, Samy Saulnier, Pierre‐Jean Ruan, Yue et al.

Source: Diabetes, Obesity & Metabolism. Jan2023, Vol. 25 Issue 1, p78-88. 11p.

Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.

Authors: Khunti, Kamlesh Ruan, Yue Davies, Jim et al.

Source: Diabetes Care. Dec2022, Vol. 45 Issue 12, p2838-2843. 6p. 1 Diagram, 2 Charts.

The potential for utilising in‐hospital glucose measurements to detect individuals at high risk of previously undiagnosed diabetes: Retrospective cohort study.

Authors: Farmer, Andrew J. Shine, Brian Armitage, Laura C. et al.

Source: Diabetic Medicine. Oct2022, Vol. 39 Issue 10, p1-9. 9p.

The change in glycaemic control immediately after COVID‐19 vaccination in people with type 1 diabetes.

Authors: Heald, Adrian H. Stedman, Michael Horne, Linda et al.

Source: Diabetic Medicine. Apr2022, Vol. 39 Issue 4, p1-10. 10p.

Inpatient hypoglycaemia in older people is associated with a doubling in the increased length of stay compared with the younger population.

Authors: Ruan, Yue Moysova, Zuzana Tan, Garry D et al.

Source: Age & Ageing. Mar2021, Vol. 50 Issue 2, p576-580. 5p. 1 Chart, 1 Graph.